Levitzki A - Search Results

1

Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model.

Golomb G, Fishbein I, Banai S, Mishaly D, Moscovitz D, Gertz SD, Gazit A, Poradosu E, Levitzki A. Golomb G, et al. Among authors: levitzki a. Atherosclerosis. 1996 Sep 6;125(2):171-82. doi: 10.1016/0021-9150(96)05868-6. Atherosclerosis. 1996. PMID: 8842349

2

Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats.

Fishbein I, Waltenberger J, Banai S, Rabinovich L, Chorny M, Levitzki A, Gazit A, Huber R, Mayr U, Gertz SD, Golomb G. Fishbein I, et al. Among authors: levitzki a. Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):667-76. doi: 10.1161/01.atv.20.3.667. Arterioscler Thromb Vasc Biol. 2000. PMID: 10712389

3

Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model.

Fishbein I, Chorny M, Banai S, Levitzki A, Danenberg HD, Gao J, Chen X, Moerman E, Gati I, Goldwasser V, Golomb G. Fishbein I, et al. Among authors: levitzki a. Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1434-9. doi: 10.1161/hq0901.095567. Arterioscler Thromb Vasc Biol. 2001. PMID: 11557668

4

Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries.

Banai S, Chorny M, Gertz SD, Fishbein I, Gao J, Perez L, Lazarovichi G, Gazit A, Levitzki A, Golomb G. Banai S, et al. Among authors: levitzki a. Biomaterials. 2005 Feb;26(4):451-61. doi: 10.1016/j.biomaterials.2004.02.040. Biomaterials. 2005. PMID: 15275819

5

Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.

Banai S, Gertz SD, Gavish L, Chorny M, Perez LS, Lazarovichi G, Ianculuvich M, Hoffmann M, Orlowski M, Golomb G, Levitzki A. Banai S, et al. Among authors: levitzki a. Cardiovasc Res. 2004 Oct 1;64(1):165-71. doi: 10.1016/j.cardiores.2004.06.013. Cardiovasc Res. 2004. PMID: 15364624

6

The effect of tyrphostin AG-556 on intimal thickening in a mouse model of arterial injury.

George J, Barshack I, Keren P, Gazit A, Levitzki A, Keren G, Roth A. George J, et al. Among authors: levitzki a. Exp Mol Pathol. 2005 Jun;78(3):233-8. doi: 10.1016/j.yexmp.2004.11.003. Epub 2005 Feb 8. Exp Mol Pathol. 2005. PMID: 15924877

7

Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.

Gazit A, Yaish P, Gilon C, Levitzki A. Gazit A, et al. Among authors: levitzki a. J Med Chem. 1989 Oct;32(10):2344-52. doi: 10.1021/jm00130a020. J Med Chem. 1989. PMID: 2552117

8

Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate.

Anafi M, Gazit A, Zehavi A, Ben-Neriah Y, Levitzki A. Anafi M, et al. Among authors: levitzki a. Blood. 1993 Dec 15;82(12):3524-9. Blood. 1993. PMID: 7505115 Free article.

9

Tyrosine kinase inhibition: an approach to drug development.

Levitzki A, Gazit A. Levitzki A, et al. Science. 1995 Mar 24;267(5205):1782-8. doi: 10.1126/science.7892601. Science. 1995. PMID: 7892601 Review.

10

Kinetics of inhibition by tyrphostins of the tyrosine kinase activity of the epidermal growth factor receptor and analysis by a new computer program.

Posner I, Engel M, Gazit A, Levitzki A. Posner I, et al. Among authors: levitzki a. Mol Pharmacol. 1994 Apr;45(4):673-83. Mol Pharmacol. 1994. PMID: 8183246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters